封面
市場調查報告書
商品編碼
1425061

藥品容器市場 - 2024 年至 2029 年預測

Pharmaceutical Container Market - Forecasts from 2024 to 2029

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 148 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

2022年藥品容器市值為447.51億美元,複合年成長率為4.26%,到2029年市場規模將達到599.27億美元。

由於醫療保健成本不斷上升以及消費者對健康生活方式的興趣日益濃厚,藥品容器的需求量很大。藥物輸送的改善、印度、泰國和中國等新興經濟體市場的擴大,以及提高患者便利性和合規性的新穎包裝解決方案將進一步推動藥品容器市場。此外,增加客戶對更好生活方式的了解將促進該行業的擴張。由於藥品市場的擴大、行業中合約包裝趨勢的增加、技術的改進以及系列化和聚合要求的應用增加,藥品包裝行業正在不斷擴大。此外,開發中國家的製藥中心正在興起,為擴大藥品包裝業務提供了巨大的機會。

介紹

藥品包裝是必備的元素。配發、分發和使用藥物可能需要包裝。法規也適用於使用說明和警告標籤的分發。藥品的包裝方法有很多種,分為一級包裝、二級包裝和三級包裝。包裹藥物的物質被稱為初級藥物包裝,而二級和三級包裝則提供進一步的外部安全性。保護產品免受環境的負面影響是包裝最重要的作用之一。保護藥品免受空氣、濕氣和光線的影響非常重要,因為許多配方在暴露於這些元素時會變得不穩定。預計市場在預測期內將大幅擴張。市場擴張是由環保和永續包裝解決方案的開發、產品創新的快速成長併購的。此外,藥品系列化追蹤和追溯系統的使用、學名藥市場的出現、藥物輸送行業的擴張、研發的增加以及尖端包裝的使用也有助於市場擴張。

促進因素

  • 全球醫療保健需求的成長將推動市場成長:COVID-19大流行、人口老化以及糖尿病、高血壓和腎臟疾病等慢性病的持續出現,都推動了過去幾年藥品的成長。帶動了產業的大幅崛起。隨著世界各地對藥品需求的增加,對包裝和運輸醫療用品(包括藥品、疫苗和醫療保健用品)的藥品容器的需求正在顯著增加。
  • 增加遠端醫療以推動成長:近年來,藥品容器市場也從遠端醫療服務的擴展中受益匪淺。人們越來越注重以患者為中心的包裝,以確保便利性和安全性,這創造了對藥品容器的需求。
  • 新興國家更多地採用學名藥將推動市場擴張:低度開發國家更多地使用學名藥將增加對藥品容器的需求。仿製學名藥藥具有相同活性成分、用法、用量、用途、副作用、給藥方法等的處方藥。包裝在學名藥生產中發揮重要作用,需要確保藥品儲存和運輸過程中的安全。
  • 永續包裝趨勢的上升正在推動擴張:醫療保健產業對環保和可回收包裝選擇的認知不斷增強,也推動了市場的發展。製造商致力於透過簡化分銷和運輸系統來減少碳排放。
  • 監管機構制定的法規也在推動市場擴張:為了確保藥品和醫療設備的完整性、有效性和安全性,監管機構制定了嚴格的規則和品質標準。藥品容器可用於滿足此類標準,並提供有效的包裝選擇,從而創造市場需求。

主要企業提供的產品

  • Corning Valor管瓶,West Pharmaceutical Services, Inc:玻璃和聚合物管瓶可滿足您從小規模開發和臨床試驗到放大和商業化的各種需求。管瓶由極其耐用的玻璃製成,具有均勻的表面化學成分,可防止分層,並且非常防碎。
  • 管瓶瓶 60ml,Amcor 公司:血清管瓶容器由 Amcor 提供。由 HDPE 製成,完全可回收。這些容器的設計符合所有行業和法規要求。

終端用戶市場中瓶裝市場顯著成長

瓶子市場已獲得主要市場佔有率,並將在預測期內繼續佔據主導地位。包括錠劑、膠囊和片劑在內的藥物必須儲存在瓶子中。瓶子提供了一層保護,使藥物遠離可能損害其品質或功效的因素,例如水分、光線和污染。該瓶子被認為是一種出色的分配器,可以幫助分配醫療保健專業人員處方的準確劑量的藥物。此外,瓶子設計有清晰的標籤和易於打開的蓋子,適合老年人和殘疾人士。隨著世界平均年齡的增加,製藥業不斷探索類似的選擇,以提供包裝解決方案,為不斷成長的受眾提高可及性和安全性。瓶裝藥品容器特別容易建造、儲存和運輸,這在醫療保健行業中非常重要。由於其彈性、安全性和與客戶的長期親和性,隨著世界各地藥品需求的增加,瓶裝容器預計將在藥品包裝行業中佔據主導地位。

北美地區預計將佔據藥品容器市場的主要佔有率:

北美佔據主要市場佔有率,預計在預測期內將以健康的複合年成長率成長。推動該地區市場擴張的主要因素是美國多家藥品製造商的存在。由於技術發展、生產方法、發明和業務整合,該行業取得了顯著成長。該地區的藥品包裝市場是由北美製藥業的擴張和多家包裝公司的存在所推動的。此外,該地區不斷成長的老年人口增加了對各種治療和療法的需求,這在過去兩年對該地區的藥品包裝行業產生了積極影響。

主要進展:

  • Amkor 是開發和製造負責任包裝解決方案的先驅,最近宣布已達成協議,將於 2023 年 1 月收購總部位於上海的 MDK。 Amkor 在亞太地區現有的強大醫療保健平台將透過加入 MDK 得到加強,並將繼續專注於具有更高成長潛力的優先類別。
  • 2022 年 9 月,Gerresheimer AG 和 Stevanato Group 宣佈建立合作夥伴關係,為製藥業創造最先進的即用管瓶平台。透過這種合作關係,客戶預計將受益於更高的效率、更高的品質標準、更快的上市時間、更低的總擁有成本 (TCO) 和更低的供應鏈風險。

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表

第2章調查方法

  • 調查資料
  • 調查過程

第3章執行摘要

  • 主要發現

第4章市場動態

  • 市場促進因素
  • 市場限制因素
  • 波特五力分析
  • 產業價值鏈分析

第5章藥品容器市場:依產品類型

  • 介紹
  • 瓶子
  • 自動販賣機
  • 其他

第6章藥品容器市場:依材料類型

  • 介紹
  • 塑膠
  • PE
  • LDPE
  • HDPE
  • 其他

第7章藥品容器市場:依最終使用者分類

  • 介紹
  • 醫院
  • 藥品
  • 診所
  • 其他

第8章醫藥容器市場:按地區

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 其他
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 台灣
    • 泰國
    • 印尼
    • 其他

第9章競爭環境及分析

  • 主要企業及策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 供應商競爭力矩陣

第10章 公司簡介

  • Amcor Plc
  • AptarGroup, Inc.
  • Origin Pharma Packaging
  • Gerresheimer AG
  • Schott Pharma
  • West Pharmaceutical Services, Inc.
  • Berry Global Inc.
  • WestRock Company
  • Comar
  • CCL Container
簡介目錄
Product Code: KSI061616091

The pharmaceutical container market is evaluated at US$44.751 billion for the year 2022 growing at a CAGR of 4.26% reaching the market size of US$59.927 billion by the year 2029.

The pharmaceutical container is in greater demand as a result of rising healthcare costs and increased consumer interest in leading healthy lifestyles. The market for pharmaceutical containers is further driven by improved medication delivery, expanding developing economy markets like India, Thailand, China, and others, and novel packaging solutions with increased patient convenience and compliance. Additionally, raising customer knowledge of a better way of life will promote industry expansion. The pharmaceutical container industry is expanding as a result of the expanding pharmaceutical market, the growing tendency of contract packaging in the industry, technical improvements, and the expanding application of serialization and aggregation requirements. Additionally, developing nations' rising pharmaceutical hubs present a considerable opportunity for the expansion of the pharmaceutical container business.

Introduction:

A pharmaceutical product's packaging is an essential component. Dispensing, dosage, and usage of pharmaceutical medication sometimes require packaging. Regulations also apply to the distribution of instructions for use and cautionary labels. A pharmaceutical product can be packaged in various distinct ways, which are categorized as main, secondary, and tertiary. The substance that encases the pharmaceutical product is known as primary medication packaging, while secondary and tertiary packaging offers extra exterior security. Protecting items from the adverse impacts of the environment is one of packaging's most crucial roles. It is important to safeguard medications against air, moisture, and light exposure since many formulations become unstable when exposed to these elements. Throughout the projected period, the market is anticipated to expand significantly. The development of environmentally friendly and sustainable packaging solutions, a surge in product innovation, and merger and acquisition to meet growing demand are all factors that have contributed to the expansion. Additionally, the use of serialized tracking and tracing systems for pharmaceuticals, the emergence of the generic medicine market, the expansion of the drug delivery industry, an increase in R&D, and the usage of cutting-edge packaging all contribute to the market's expansion.

Drivers:

  • Growing demand for healthcare worldwide will fuel market growth: The COVID-19 pandemic, the aging population, and the ongoing incidence of chronic illnesses including diabetes, hypertension, and kidney ailments have all contributed to the pharmaceutical industry's significant rise over the past few years. The need for pharmaceutical containers to package and transport medical items including pharmaceuticals, vaccines, and healthcare supplies is significantly increasing as the demand for medications throughout the world rises.
  • Rise in telemedicine to boost growth: The market for pharmaceutical containers has also benefited greatly from the expansion of telemedicine services over the past several years. To guarantee ease and security, there has been an increased emphasis on patient-centered packaging which is creating demand for pharmaceutical containers.
  • Increased generic drug adoption in developing nations will support market expansion: The growing use of generic medications in underdeveloped nations will increase demand for pharmaceutical containers due to their low cost. A generic medicine is a prescription medication that shares the same active components, dosage, intended purpose, adverse effects, and mode of administration as the brand-name medication. Since packaging is required to store and safeguard medications during storage and transportation, it plays a significant role in the production of generic medications. The increasing demand for generic medications will hence increase product utilization.
  • Growing trend towards sustainable packaging is fueling expansion: The healthcare industry's growing awareness of eco-friendly and recyclable packaging options has also fueled the market. Manufacturers are concentrating on reducing their carbon footprint by streamlining the distribution and transportation systems.
  • Rules framed by regulatory authorities also boost market expansion: To guarantee the integrity, effectiveness, and safety of medicines and medical equipment, regulatory agencies create strict rules and quality standards. Pharmaceutical containers can be used to meet these standards, which also offer efficient packaging options thus, creating the market demand.

Products offered by key companies:

  • Corning Valor Glass Vials, West Pharmaceutical Services, Inc.: Glass and polymer vials are available from West to satisfy a variety of client demands, from small-scale development and clinical trials to scale-up and commercialization. Vials are manufactured of incredibly durable glass, which displays homogeneous surface chemistry to prevent delamination and is extremely robust against shattering.
  • Serum Vial Bottle 60 ml, Amcor: Serum vial container is offered by Amcor. It is made up of HDPE and is completely recyclable. These containers are designed to meet all industry as well as regulatory requirements.

The prominent growth in the bottles sector under the End-User segment

The bottles segment captured the major market share and is likely to dominate over the forecast period. Pharmaceutical items including pills, capsules, and tablets must be stored in bottles. They offer a layer of defense that keeps medicines away from elements like moisture, light, and contamination that might harm their quality and potency. They are regarded as excellent dispensers that can assist people in dispensing the precise amount of medication prescribed by healthcare professionals. Additionally, bottles are designed with clear labelling and easy-to-open lids to accommodate elderly and disabled individuals. The pharmaceutical business is continually looking for alternatives like these that offer packaging solutions to increase accessibility and safety for this expanding audience as the average worldwide age rises. Bottled pharmaceutical containers are particularly simple to construct, store, and transport, which is important in the healthcare industry. Because of their flexibility, safety, and long-term familiarity with customers, bottled containers are expected to dominate the pharmaceutical container industry as the need for drugs throughout the world rises.

The North American region is expected to hold a significant share of the pharmaceutical container market:

North America held the major market share and is anticipated to grow at a healthy CAGR over the projection period. The main element fueling market expansion in the region is the existence of several pharmaceutical producers in the U.S. The industry has grown substantially as a consequence of technological developments, production methods, inventions, and corporate integration. The regional pharmaceutical container market is being driven by expansion in the pharmaceutical sector in North America and the existence of several packaging firms. Additionally, the growing geriatric population in the area has increased demand for a variety of treatments and therapies, favourably impacting the regional pharmaceutical container industry during the past two years.

Key developments:

  • Amcor, a pioneer in responsible packaging solutions development and production, recently announced that it has signed a contract to buy Shanghai-based MDK in January 2023. Amcor's existing robust healthcare platform in the Asia-Pacific region will be strengthened by the inclusion of MDK as it maintains its concentration on higher growth priority categories.
  • Gerresheimer AG and Stevanato Group announced a partnership in September 2022 to create a cutting-edge Ready-to-use Vial Platform for the Pharmaceutical Industry. Customers are expected to benefit from increased efficiency, higher quality standards, quicker time to market, lower total cost of ownership (TCO), and reduced supply chain risk thanks to this partnership.

SEGMENTS:

BY PRODUCT TYPE

  • Bottles
  • Dispensing
  • Jars
  • Others

BY MATERIAL TYPE

  • Plastic
  • PE
  • LDPE
  • HDPE
  • Others

BY END-USER

  • Hospital
  • Pharmaceutical
  • Clinics
  • Others

BY GEOGRAPHY

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. PHARMACEUTICAL CONTAINER MARKET, BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. Bottles
  • 5.3. Dispensing
  • 5.4. Jars
  • 5.5. Others

6. PHARMACEUTICAL CONTAINER MARKET, BY MATERIAL TYPE

  • 6.1. Introduction
  • 6.2. Plastic
  • 6.3. PE
  • 6.4. LDPE
  • 6.5. HDPE
  • 6.6. Others

7. PHARMACEUTICAL CONTAINER MARKET, BY END-USER

  • 7.1. Introduction
  • 7.2. Hospital
  • 7.3. Pharmaceutical
  • 7.4. Clinics
  • 7.5. Others

8. PHARMACEUTICAL CONTAINER MARKET, BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. United States
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. United Kingdom
    • 8.4.2. Germany
    • 8.4.3. France
    • 8.4.4. Italy
    • 8.4.5. Spain
    • 8.4.6. Others
  • 8.5. The Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. India
    • 8.6.4. South Korea
    • 8.6.5. Taiwan
    • 8.6.6. Thailand
    • 8.6.7. Indonesia
    • 8.6.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Vendor Competitiveness Matrix

10. COMPANY PROFILES

  • 10.1. Amcor Plc
  • 10.2. AptarGroup, Inc.
  • 10.3. Origin Pharma Packaging
  • 10.4. Gerresheimer AG
  • 10.5. Schott Pharma
  • 10.6. West Pharmaceutical Services, Inc.
  • 10.7. Berry Global Inc.
  • 10.8. WestRock Company
  • 10.9. Comar
  • 10.10. CCL Container